90 positions · $341M portfolio reported
7 positions · $480M portfolio reported
16 positions · $213M portfolio reported
587 positions · $3.1B portfolio reported
399 positions · $14.4B portfolio reported
10 positions · $203M portfolio reported
91 positions · $403M portfolio reported
158 positions · $456M portfolio reported
21 positions · $148M portfolio reported
70 positions · $5.1B portfolio reported
38 positions · $127M portfolio reported
194 positions · $3.0B portfolio reported
24 positions · $11.6B portfolio reported
40 positions · $80M portfolio reported
42 positions · $3.2B portfolio reported
7 positions · $1.3B portfolio reported
21 positions · $3.2B portfolio reported
216 positions · $20.8B portfolio reported
55 positions · $91M portfolio reported
124 positions · $65M portfolio reported
Amendment to 13G — 8.8% in JATT II Acquisition Corp.
Passive 5.1% disclosure in JATT III Acquisition Corp
Passive 8.7% disclosure in Fulcrum Therapeutics, Inc.
Amendment to 13G — 9.9% in Research Alliance Corporation III
Amendment to 13G — 9.9% in Grace Therapeutics, Inc.
Amendment to 13G — 6.6% in BANK OF AMERICA CORPORATION
Amendment to 13G — 5.9% in THE KROGER CO.
Amendment to 13G — 0.0% in USIO, Inc.
Passive 6.4% disclosure in BENDING SPOONS S.p.A.
Amendment to 13G — 4.7% in DTF TAX-FREE INCOME 2028 TERM FUND INC
Amendment to 13G — 14.1% in PIMCO Dynamic Income Strategy Fund
Amendment to 13G — 6.4% in SkyAI, Inc.
Amendment to 13G — 10.0% in Fusion Fuel Green PLC
Amendment to 13G — 0.3% in Safehold Inc.
Passive 7.4% disclosure in Inovio Pharmaceuticals, Inc.
Passive 6.8% disclosure in Research Alliance Corp IV
Passive 5.5% disclosure in TCGX Acquisition Corp.
Passive 6.0% disclosure in Enanta Pharmaceuticals Inc.
Amendment to 13G — 2.5% in Yarrow Bioscience, Inc.
Amendment to 13G — 1.5% in Freenome, Inc.